Literature DB >> 17485607

Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress.

Alipi V Naydenov1, Matthew L MacDonald, Dost Ongur, Christine Konradi.   

Abstract

CONTEXT: Bipolar disorder (BPD) is among the top 10 causes of disability worldwide. Recent findings on the etiology of the disease point to a disturbed mitochondrial energy metabolism in the brain of subjects with BPD.
OBJECTIVE: To test whether gene transcripts for proteins of the mitochondrial respiratory chain have altered levels in glucose-deprived lymphocytes from patients with BPD.
DESIGN: Microarrays were used to measure gene expression levels in fresh lymphocytes and in lymphocytes cultured for 5 days in regular or low-glucose medium.
SETTING: Subjects with BPD were recruited through the Schizophrenia and Bipolar Disorders Program, McLean Hospital, Belmont, Mass. Controls were recruited through advertising. Patients A total of 21 patients with BPD (inpatients and outpatients) and 21 control subjects. Main Outcome Measure Expression levels for genes of proteins involved in mitochondrial respiration.
RESULTS: We found an opposite molecular response of control and BPD lymphocytes to glucose deprivation. Whereas lymphocytes of normal controls responded to glucose deprivation with an up-regulation of nuclear transcripts for proteins of the electron transfer chain, subjects with BPD had a tendency to down-regulate these transcripts.
CONCLUSIONS: The results suggest that the normal molecular adaptation to energy stress is deficient in lymphocytes from patients with BPD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485607     DOI: 10.1001/archpsyc.64.5.555

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  38 in total

1.  Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder.

Authors:  Rodrigo Machado-Vieira; Marcus V Zanetti; Antonio L Teixeira; Miyuki Uno; Leandro L Valiengo; Marcio G Soeiro-de-Souza; Sueli M Oba-Shinjo; Rafael T de Sousa; Carlos A Zarate; Wagner F Gattaz; Suely K N Marie
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-16       Impact factor: 4.600

Review 2.  Convergent Functional Genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers.

Authors:  H Le-Niculescu; M J McFarland; S Mamidipalli; C A Ogden; R Kuczenski; S M Kurian; D R Salomon; Ming T Tsuang; J I Nurnberger; A B Niculescu
Journal:  Neurosci Biobehav Rev       Date:  2007-06-03       Impact factor: 8.989

Review 3.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

4.  Regulation of glycogen synthase kinase-3 during bipolar mania treatment.

Authors:  Xiaohong Li; Min Liu; Zhuoji Cai; Gang Wang; Xiaohua Li
Journal:  Bipolar Disord       Date:  2010-11       Impact factor: 6.744

5.  Exon Array Biomarkers for the Differential Diagnosis of Schizophrenia and Bipolar Disorder.

Authors:  Marquis Philip Vawter; Robert Philibert; Brandi Rollins; Patricia L Ruppel; Terry W Osborn
Journal:  Mol Neuropsychiatry       Date:  2018-04-10

6.  3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder.

Authors:  Ana Cristina Andreazza; Flavio Kapczinski; Marcia Kauer-Sant'Anna; Julio C Walz; David J Bond; Carlos A Gonçalves; L Trevor Young; Lakshmi N Yatham
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

7.  Brain cytochrome-c-oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS.

Authors:  Lisa Holper; Martin J Lan; Patrick J Brown; Elizabeth M Sublette; Ainsley Burke; John J Mann
Journal:  Depress Anxiety       Date:  2019-05-21       Impact factor: 6.505

8.  Physical Exercise for Treatment of Mood Disorders: A Critical Review.

Authors:  C M Hearing; W C Chang; K L Szuhany; T Deckersbach; A A Nierenberg; L G Sylvia
Journal:  Curr Behav Neurosci Rep       Date:  2016-10-14

9.  The somatic common deletion in mitochondrial DNA is decreased in schizophrenia.

Authors:  Firoza Mamdani; Brandi Rollins; Ling Morgan; P Adolfo Sequeira; Marquis P Vawter
Journal:  Schizophr Res       Date:  2014-09-28       Impact factor: 4.939

10.  Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.

Authors:  Maureen V Martin; Brandi Rollins; P Adolfo Sequeira; Andrea Mesén; William Byerley; Richard Stein; Emily A Moon; Huda Akil; Edward G Jones; Stanley J Watson; Jack Barchas; Lynn E DeLisi; Richard M Myers; Alan Schatzberg; William E Bunney; Marquis P Vawter
Journal:  BMC Med Genomics       Date:  2009-09-22       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.